{"id":"W2530861981","doi":"10.1182/blood.v110.11.308.308","title":"Rivaroxaban - An Oral, Direct Factor Xa Inhibitor - for Thromboprophylaxis after Total Knee Arthoplasty: The RECORD3 Trial.","year":2007,"lang":"en","type":"article","venue":"Blood","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Surgery; Deep vein; Thrombosis; Population; Adverse effect; Randomized controlled trial; Enoxaparin sodium; Venous thrombosis; Internal medicine; Low molecular weight heparin; Warfarin; Atrial fibrillation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001421813,0.0007398835,0.001479095,0.0001902186,0.0002441904,0.000921737,0.0004054566,0.0009579321,0.005457035],"category_scores_gemma":[0.001017947,0.0002194318,0.001909481,0.0004175822,0.0003956936,0.0004521178,0.0002283063,0.00132244,0.000704064],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003762408,"about_ca_system_score_gemma":0.0008323308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006538374,"about_ca_topic_score_gemma":0.001357763,"domain_scores_codex":[0.9994172,0.0003038725,0.00005694463,0.00008930174,0.00005616426,0.00007659128],"domain_scores_gemma":[0.9995077,0.0001162084,0.0002043899,0.00003456854,0.00002728351,0.0001099206],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9459937,0.002580779,0.003374167,0.002822418,0.002549097,0.0001039082,0.00004718454,0.0004452934,0.002764281,0.0004894245,0.004608543,0.03422126],"study_design_scores_gemma":[0.9594247,0.02733443,0.006338531,0.0001599049,0.001892708,0.0001765734,0.00001816924,0.0004517312,0.0005412658,0.0002838336,0.003362476,0.00001572169],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9174899,0.05948614,0.001280981,0.002439485,0.001067639,0.00290741,0.007814386,0.0001790348,0.007335114],"genre_scores_gemma":[0.9620607,0.01704185,0.001812837,0.001788397,0.001029567,0.003388298,0.006373096,0.00003256073,0.006472597],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005457035,"threshold_uncertainty_score":0.01825565,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02107567603180242,"score_gpt":0.2821854435561459,"score_spread":0.2611097675243435,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}